Literature DB >> 22156861

Permanent ostomy after ileoanal pouch failure: pouch in situ or pouch excision?

Ravi P Kiran1, Hasan T Kirat, Matteo Rottoli, Xhileta Xhaja, Feza H Remzi, Victor W Fazio.   

Abstract

BACKGROUND: The risks and benefits of pouch excision and end ileostomy creation when compared to the alternative option of a permanent diversion with the pouch left in situ when restoration of intestinal continuity is not pursued for patients who develop pouch failure after IPAA have not been well characterized.
OBJECTIVE: This study aimed to compare the early and long-term outcomes after permanent diversion with the pouch left in situ vs pouch excision with end ileostomy creation for pouch failure.
DESIGN: This study is a retrospective review of prospectively gathered data. SETTINGS: This investigation was conducted at a tertiary center. PATIENTS: Patients with pouch failure who underwent a permanent ileostomy with the pouch left in situ and those who underwent pouch excision were included in the study. MAIN OUTCOME MEASURES: The primary outcomes measured were the perioperative outcomes and quality of life using the pouch and Short Form 12 questionnaires.
RESULTS: One hundred thirty-six patients with pouch failure underwent either pouch left in situ (n = 31) or pouch excision (n = 105). Age (p = 0.72), sex (p = 0.72), ASA score (p = 0.22), BMI (p = 0.83), disease duration (p = 0.74), time to surgery for pouch failure (p = 0.053), diagnosis at pouch failure (p = 0.18), and follow-up (p = 0.76) were similar. The predominant reason for pouch failure was septic complications in 15 (48.4%) patients in the pouch left in situ group and 39 (37.1%) patients in the pouch excision group (p = 0.3). Thirty-day complications, including prolonged ileus (p = 0.59), pelvic abscess (p = 1.0), wound infection (p = 1.0), and bowel obstruction (p = 1.0), were similar. At the most recent follow-up (median, 9.9 y), quality of life (p = 0.005) and health (p = 0.008), current energy level (p = 0.026), Cleveland Global Quality of Life score (p = 0.005), and Short Form 12 mental (p = 0.004) and physical (p = 0.014) component scales were significantly higher after pouch excision than after pouch left in situ. Urinary and sexual function was similar between the groups. Anal pain (n = 4) and seepage with pad use (n = 8) were the predominant concerns of the pouch left in situ group on long-term follow-up. None of the 18 patients with pouch in situ, for whom information relating to long-term pouch surveillance was available, developed dysplasia or cancer. LIMITATIONS: This study was limited by its retrospective nature.
CONCLUSIONS: Although technically more challenging, pouch excision, rather than pouch left in situ, is the preferable option for patients who develop pouch failure and are not candidates for restoration of intestinal continuity. Because pouch left in situ was not associated with neoplasia, this option is a reasonable intermediate or long-term alternative when pouch excision is not feasible or advisable.

Entities:  

Mesh:

Year:  2012        PMID: 22156861     DOI: 10.1097/DCR.0b013e3182312a8a

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  Diverted versus undiverted restorative proctocolectomy for chronic ulcerative colitis: an analysis of long-term outcomes after pouch leak short title: outcomes after pouch leak.

Authors:  Maria Widmar; Jordan A Munger; Alex Mui; Stephen R Gorfine; David B Chessin; Daniel A Popowich; Joel J Bauer
Journal:  Int J Colorectal Dis       Date:  2019-01-25       Impact factor: 2.571

Review 2.  The Failed J Pouch.

Authors:  Emmanouil P Pappou; Ravi P Kiran
Journal:  Clin Colon Rectal Surg       Date:  2016-06

3.  Characterization of megapouch in patients with restorative proctocolectomy.

Authors:  Preeti Shashi; Bo Shen
Journal:  Surg Endosc       Date:  2018-10-16       Impact factor: 4.584

4.  Perineal wound healing following ileoanal pouch excision.

Authors:  Pasha J Nisar; Matthias Turina; Ian C Lavery; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2013-10-22       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.